Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group

MLA

Kok, T. C., et al. “Cisplatin and Etoposide in Oesophageal Cancer: A Phase II Study. Rotterdam Oesophageal Tumour Study Group.” British Journal of Cancer, vol. 74, no. 6, Jan. 1996, pp. 980–84. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........930351ef135ffab180cdfaf391c676f1&authtype=sso&custid=ns315887.

APA

Kok, T. C., Van der Gaast, A., Dees, J., Eykenboom, W. M., Van Overhagen, H., Stoter, G., Tilanus, H. W., & Splinter, T. A. (1996). Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group. British Journal of Cancer, 74(6), 980–984.

Chicago

Kok, T. C., A. Van der Gaast, J. Dees, W. M. Eykenboom, H. Van Overhagen, G. Stoter, H. W. Tilanus, and T. A. Splinter. 1996. “Cisplatin and Etoposide in Oesophageal Cancer: A Phase II Study. Rotterdam Oesophageal Tumour Study Group.” British Journal of Cancer 74 (6): 980–84. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........930351ef135ffab180cdfaf391c676f1&authtype=sso&custid=ns315887.